AstraZeneca could supply a vaccine from September

AstraZeneca could supply potential coronavirus vaccine from September

AstraZeneca has said it has the capacity to manufacture 1bn doses of the University of Oxford’s potential Covid-19 vaccine and will begin supply in September if clinical trials are successful. The Anglo-Swedish drugmaker said it had signed the first agreements to supply at least 400m doses of the potential vaccine, yet to be proven effective, which it is developing with the university.

By Jo

Leave a Reply

Your email address will not be published. Required fields are marked *